Learn

Seroquel for Sleep: Why It Is Rarely the Right Choice

Quetiapine is sedating, which is why it sometimes gets prescribed for sleep. It is also an antipsychotic, not a sleep medicine, and it comes with real risks.

The short answer

  • Seroquel (quetiapine) is an atypical antipsychotic approved for schizophrenia and bipolar disorder. Insomnia is not an approved indication.
  • It carries a boxed warning covering increased mortality in elderly patients with dementia-related psychosis, and suicidal thoughts and behaviors.
  • Because it is sedating, quetiapine is sometimes prescribed at low doses for sleep. That is off-label — the FDA has not approved it for that use.
  • The guidelines point away from it. The 2025 VA/DoD guideline suggests against antipsychotics for chronic insomnia, the 2023 European guideline does not recommend them, and the Beers Criteria advise avoiding them in older adults outside approved indications.
  • If it was prescribed for sleep alone, it is fair to ask your prescriber why it was chosen and whether CBT-I has been considered. Do not stop it on your own — stopping abruptly can cause withdrawal symptoms.

CBT-I = cognitive behavioral therapy for insomnia · FDA = US Food and Drug Administration · VA = US Department of Veterans Affairs

For education only, and not a substitute for advice from your own doctor or prescriber.

Quick check

Do your answers fit the pattern for insomnia?

Four yes/no questions, about thirty seconds. Your result shows straight away, and no email is needed.

Do you have difficulty falling asleep or staying asleep for 3 or more nights a week?
Question 1 of 4

Seroquel is the brand name for quetiapine, an antipsychotic approved for schizophrenia and bipolar disorder. It is also prescribed off-label for other things, including anxiety, PTSD and insomnia. Because drowsiness is a common effect, some prescribers use it at low doses for people who cannot sleep. It carries less risk of dependence than benzodiazepines when used this way — but it is not generally recommended for long-term insomnia. If you have been prescribed it and gone looking for whether it works for sleep, the useful starting point is what the drug actually is.

What Seroquel is approved for

Quetiapine is an atypical antipsychotic, first approved in 1997, available as immediate-release and extended-release tablets. The immediate-release tablets are indicated for schizophrenia and for manic or depressive episodes of bipolar disorder; the extended-release form adds major depressive disorder as an add-on to antidepressants.1

Insomnia is not among them.

The label carries a boxed warning covering two things: increased mortality in elderly patients with dementia-related psychosis, and suicidal thoughts and behaviors.1 Beyond that, the warnings section runs to metabolic changes — weight gain, high blood sugar, abnormal lipids — along with low blood pressure, QT prolongation, cataracts, seizures, tardive dyskinesia, and withdrawal symptoms if it is stopped abruptly.1

Why it gets prescribed for sleep anyway

Quetiapine is strongly sedating, and it does not carry the dependence and tolerance problems of benzodiazepines and Z-drugs.

For someone with anxiety, low mood or PTSD symptoms on top of insomnia, a prescriber may judge it a reasonable option — or reach for it when other things have not worked. Off-label prescribing is legal and common, and it rests on the clinician's judgment rather than on an approved indication.

The guidelines, though, are not neutral on it. The AASM's 2017 guideline on insomnia medications graded fourteen drugs, and quetiapine was not among them, so that guideline makes no recommendation on it. A randomized trial of quetiapine for insomnia is cited in the guideline's own references, so the silence is an absence of a recommendation rather than an absence of literature.6 The 2025 VA/DoD guideline does: it suggests against antipsychotic drugs for chronic insomnia.3 The 2023 European guideline does not recommend them either.4 And the Beers Criteria advise avoiding antipsychotics in older adults except for approved indications such as schizophrenia and bipolar disorder.5

What the label's safety data do and do not tell you

The label's safety figures come from people taking quetiapine at the doses used for schizophrenia and bipolar disorder — far higher than a low nightly dose for sleep. In short-term schizophrenia trials, 23% of people on Seroquel gained 7% or more of their body weight, against 6% on placebo. Total cholesterol reached 240 mg/dL or higher in 18%, against 7% on placebo.1 The label also warns about hyperglycemia severe enough in rare cases to cause ketoacidosis, coma or death, and about tardive dyskinesia, which can be permanent.1

Those percentages do not transfer directly to a low off-label dose, and it would be misleading to read them that way.

What would be equally misleading is to assume a low dose carries none of these risks. The label does not say that, and its warnings do not define a safe dose. A 2021 review of low-dose quetiapine for insomnia found metabolic effects — weight gain, and increases in BMI and fasting blood glucose — in studies of doses under 100 to 200 mg a day, and recommended monitoring weight, blood pressure, glucose and lipids even at those doses.2

The honest summary: the risks at low off-label doses are less well studied than the risks at approved doses, and what has been studied is not reassuring.

The bottom line

For some people — particularly where a psychiatric condition is being treated at the same time — quetiapine prescribed and monitored by a clinician may be a reasonable option. But for many people taking it, insomnia is not the main thing it is treating.

A question worth asking: was this prescribed for my sleep, and if so, what else was considered?

For long-term insomnia on its own, the guidelines recommend CBT-I as the initial treatment.78 If you have not tried it, it is worth raising. It does not interact with quetiapine and does not require stopping it — it is something you add, not a switch.

And do not stop quetiapine on your own. Stopping abruptly can cause withdrawal symptoms; the dose should be lowered gradually with your prescriber.1

Common questions

Is Seroquel approved for insomnia?
No. The label indicates it for schizophrenia and for manic and depressive episodes of bipolar disorder, with the extended-release form also approved as an add-on in major depressive disorder. Prescribing it for sleep is off-label.
Why do doctors prescribe Seroquel for sleep then?
It is strongly sedating at low doses and does not carry the dependence problems of benzodiazepines. For someone who has not responded to other options, or who has a psychiatric condition alongside insomnia, a prescriber may judge that the benefits outweigh the risks.
Is a low dose of Seroquel safe for sleep?
The label's safety data come from trials at the much higher doses used in schizophrenia and bipolar disorder, so those figures do not transfer directly. But low doses are not risk-free either — a 2021 review of low-dose use for insomnia found weight gain and increases in BMI and fasting blood glucose, and advised monitoring weight, blood pressure, glucose and lipids even at those doses.
Does Seroquel appear in the insomnia treatment guidelines?
Mostly to advise against it. The AASM's 2017 guideline graded fourteen drugs and quetiapine was not among them, so it makes no recommendation on it. The 2025 VA/DoD guideline suggests against antipsychotics for chronic insomnia, and the 2023 European guideline does not recommend them.
Can I just stop taking it?
Not abruptly. Stopping suddenly can cause withdrawal symptoms, so the dose should be lowered gradually with your prescriber.

References

  1. SEROQUEL (quetiapine fumarate) prescribing information (revised 4/2025). Boxed Warning; Indications and Usage; Warnings and Precautions; Adverse Reactions. DailyMed, US National Library of Medicine.
  2. Modesto-Lowe V, Harabasz AK, Walker SA. Quetiapine for primary insomnia: consider the risks. Cleveland Clinic Journal of Medicine. 2021;88(5):286-294. doi:10.3949/ccjm.88a.20031
  3. VA/DoD Clinical Practice Guideline for the Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea. Version 3.0. US Department of Veterans Affairs and Department of Defense; 2025.
  4. Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research. 2023;32(6):e14035. doi:10.1111/jsr.14035
  5. American Geriatrics Society. 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):2052-2081. doi:10.1111/jgs.18372
  6. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349. doi:10.5664/jcsm.6470
  7. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133.
  8. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262. doi:10.5664/jcsm.8986

Next in this path

Do I have insomnia?A few quick questions
Take it